Clinical • Real-world evidence • Real-world
|
KRAS (KRAS proto-oncogene GTPase) • TP53 (Tumor protein P53) • STK11 (Serine/threonine kinase 11) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • KEAP1 (Kelch Like ECH Associated Protein 1) • SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 4)
|
TP53 mutation • KRAS G12C • STK11 mutation • KEAP1 mutation • CDKN2A mutation • KRAS G12 • SMARCA4 mutation